Enhabit, Inc. (NYSE:EHAB) Shares Sold by Orion Portfolio Solutions LLC

Orion Portfolio Solutions LLC decreased its holdings in Enhabit, Inc. (NYSE:EHABFree Report) by 38.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 70,815 shares of the company’s stock after selling 43,370 shares during the quarter. Orion Portfolio Solutions LLC owned 0.14% of Enhabit worth $553,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of EHAB. FMR LLC raised its stake in shares of Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after buying an additional 1,967 shares during the period. Quantbot Technologies LP acquired a new position in Enhabit during the fourth quarter worth $45,000. Corient Private Wealth LLC purchased a new position in Enhabit during the fourth quarter valued at $79,000. Intech Investment Management LLC acquired a new stake in shares of Enhabit in the third quarter valued at about $96,000. Finally, Stoneridge Investment Partners LLC increased its stake in shares of Enhabit by 22.6% during the fourth quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock worth $98,000 after purchasing an additional 2,308 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

View Our Latest Report on Enhabit

Enhabit Trading Down 2.8 %

Shares of EHAB opened at $7.93 on Tuesday. Enhabit, Inc. has a 52-week low of $6.85 and a 52-week high of $11.35. The stock has a market cap of $400.05 million, a PE ratio of -3.42 and a beta of 1.60. The firm’s fifty day moving average is $8.57 and its two-hundred day moving average is $8.00. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.85.

Enhabit Company Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Further Reading

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.